TIDMODX

RNS Number : 2242A

Omega Diagnostics Group PLC

20 January 2020

20 January 2020

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Exercise of Options and Total Voting Rights

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has allotted 80,000 new ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") following the exercise of share options by an ex-employee.

Application has been made to the London Stock Exchange for the 80,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 23 January 2020.

After Admission, the total number of Ordinary Shares in issue will be 150,387,010 and the total number of voting rights will therefore be 150,387,010. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Contacts:

 
 Omega Diagnostics Group PLC                                  Tel: 01259 763 030 
 Bill Rhodes, Interim Non-Executive                     www.omegadiagnostics.com 
  Chairman 
  Colin King, Chief Executive 
 Kieron Harbinson, Group Finance 
  Director 
 
 
 finnCap Ltd                                                  Tel: 020 7220 0500 
 Geoff Nash/Hannah Boros (Corporate 
  Finance) 
 Camille Gochez (Corporate Broking) 
 
 Walbrook PR Limited                  Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                                 Mob: 07980 541 893 
 Lianne Cawthorne                                             Mob: 07584 391 303 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOESFDFMWESSEEF

(END) Dow Jones Newswires

January 20, 2020 02:00 ET (07:00 GMT)

Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Omega Diagnostics
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Omega Diagnostics